ArticleFEBS open bio2018

Augmentation of the therapeutic efficacy of WEE1 kinase inhibitor AZD1775 by inhibiting the YAP-E2F1-DNA damage response pathway axis.

Yusuke Oku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.